11 results
Prophylaxis Against Opportunistic Infections in Persons with Human Immunodeficiency Virus Infection
#Pharm #Management #CD4Count #AIDS #HIV #Prophylaxis
Prophylaxis Against Opportunistic ... Immunodeficiency Virus ... #Management #CD4Count ... #Prophylaxis #Antibiotics ... #Opportunistic
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... • Hepatitis A virus ... #Prophylaxis #Opportunistic ... HIVAIDS #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... • Hepatitis A virus ... #Prophylaxis #Opportunistic ... HIVAIDS #IDSA #management ... #pharmacology
Antifungal Polyenes - Amphoterecin B, Abelcet, Ambisome - Antibiotics Class Overview

Mechanism: binds ergosterol in membrane and
Antifungal Polyenes ... Abelcet, Ambisome - Antibiotics ... severe fungal infections ... #Pharmacology #Antibiotics ... #Review #Overview
Flutycosine - Antibiotics Class Overview
 - 
Mechanism: 5-FC interferes with DNA and protein synthesis.  Only
Flutycosine - Antibiotics ... B for initial management ... #Pharmacology #Antibiotics ... #Review #Overview ... #Flutycosine #Antifungal
Antifungal Echinocandins  - Antibiotics Class Overview

Mechanism: Inhibit glucan synthesis in fungal cell wall by blocking
Antifungal Echinocandins ... - Antibiotics ... severe Candida infections ... Anidulafungin #Pharmacology ... #Antibiotics #Review
Coverage of common antibiotics used in the hospital

For empiric coverage, first define the type of infection,
Coverage of common antibiotics ... define the type of infection ... , then review prior ... ampicillin #management ... #antibiogram #pharmacology
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
previously diagnosed opportunistic ... of preexisting opportunistic ... • Treat for opportunistic ... -6 weeks after antifungal ... Differential #Diagnosis #Management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Note: Systemic antifungals ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
Herpes Simplex Virus ... (HSV) Infections ... Prevention #Treatment #management ... #opportunistic ... #pharmacology